Follow
Sarah Stanley
Sarah Stanley
Verified email at berkeley.edu
Title
Cited by
Cited by
Year
Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system
SA Stanley, S Raghavan, WW Hwang, JS Cox
Proceedings of the National Academy of Sciences 100 (22), 13001-13006, 2003
7462003
The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis
SA Stanley, JE Johndrow, P Manzanillo, JS Cox
The Journal of Immunology 178 (5), 3143-3152, 2007
5202007
Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
SA Stanley, SS Grant, T Kawate, N Iwase, M Shimizu, C Wivagg, M Silvis, ...
ACS chemical biology 7 (8), 1377-1384, 2012
3122012
Identification of Host-Targeted Small Molecules That Restrict Intracellular Mycobacterium tuberculosis Growth
SA Stanley, AK Barczak, MR Silvis, SS Luo, K Sogi, M Vokes, MA Bray, ...
PLoS pathogens 10 (2), e1003946, 2014
2822014
C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis
PADG Champion, SA Stanley, MM Champion, EJ Brown, JS Cox
Science 313 (5793), 1632-1636, 2006
2822006
A non‐RD1 gene cluster is required for Snm secretion in Mycobacterium tuberculosis
JA MacGurn, S Raghavan, SA Stanley, JS Cox
Molecular microbiology 57 (6), 1653-1663, 2005
2422005
HIF-1α is an essential mediator of IFN-γ–dependent immunity to Mycobacterium tuberculosis
J Braverman, KM Sogi, D Benjamin, DK Nomura, SA Stanley
The Journal of Immunology 197 (4), 1287-1297, 2016
2402016
Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense
M Knight, J Braverman, K Asfaha, K Gronert, S Stanley
PLoS pathogens 14 (1), e1006874, 2018
2102018
The Innate Immune Response to Mycobacterium tuberculosis Infection
MM Ravesloot-Chávez, E Van Dis, SA Stanley
Annual review of immunology 39 (1), 611-637, 2021
1492021
Nitric oxide modulates macrophage responses to Mycobacterium tuberculosis infection through activation of HIF-1α and repression of NF-κB
J Braverman, SA Stanley
The Journal of Immunology 199 (5), 1805-1816, 2017
1472017
SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA
A Jack, LS Ferro, MJ Trnka, E Wehri, A Nadgir, X Nguyenla, D Fox, ...
PLoS biology 19 (10), e3001425, 2021
1432021
Host–Pathogen Interactions During Mycobacterium tuberculosis infections
SA Stanley, JS Cox
Pathogenesis of Mycobacterium tuberculosis and its interaction with the host …, 2013
1382013
RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities
AK Barczak, JE Gomez, BB Kaufmann, ER Hinson, L Cosimi, ...
Proceedings of the national academy of sciences 109 (16), 6217-6222, 2012
1302012
STING-activating adjuvants elicit a Th17 immune response and protect against Mycobacterium tuberculosis infection
E Van Dis, KM Sogi, CS Rae, KE Sivick, NH Surh, ML Leong, DB Kanne, ...
Cell reports 23 (5), 1435-1447, 2018
1252018
Stereocontrol in intermolecular dirhodium (II)-catalyzed carbonyl ylide formation and reactions. Dioxolanes and dihydrofurans
MP Doyle, DC Forbes, MN Protopopova, SA Stanley, MM Vasbinder, ...
The Journal of Organic Chemistry 62 (21), 7210-7215, 1997
1241997
Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32
SA Stanley, T Kawate, N Iwase, M Shimizu, AE Clatworthy, ...
Proceedings of the National Academy of Sciences 110 (28), 11565-11570, 2013
1162013
T cell-intrinsic requirement for NF-κB induction in postdifferentiation IFN-γ production and clonal expansion in a Th1 response
RA Corn, MA Aronica, F Zhang, Y Tong, SA Stanley, SRA Kim, ...
The Journal of Immunology 171 (4), 1816-1824, 2003
1132003
Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model
SS Grant, T Kawate, PP Nag, MR Silvis, K Gordon, SA Stanley, ...
ACS chemical biology 8 (10), 2224-2234, 2013
932013
Rapid detection of SARS-CoV-2 RNA in saliva via Cas13
SS Chandrasekaran, S Agrawal, A Fanton, AR Jangid, B Charrez, ...
Nature biomedical engineering 6 (8), 944-956, 2022
922022
Synthesis and structure–activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32
T Kawate, N Iwase, M Shimizu, SA Stanley, S Wellington, E Kazyanskaya, ...
Bioorganic & medicinal chemistry letters 23 (22), 6052-6059, 2013
862013
The system can't perform the operation now. Try again later.
Articles 1–20